BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1392 related articles for article (PubMed ID: 19263173)

  • 1. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
    Yang W; Li XY
    Chin Med J (Engl); 2005 Feb; 118(4):296-301. PubMed ID: 15740667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation.
    Wu N; Jin SZ; Pan XN; Liu SZ
    Int J Radiat Biol; 2008 Mar; 84(3):201-10. PubMed ID: 18300020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
    Luo X; Slater JM; Gridley DS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
    Tai KF; Chen PJ; Chen DS; Hwang LH
    J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice.
    Li J; Dong X; Xu Z; Jiang X; Jiang H; Krissansen GW; Sun X
    J Biomed Sci; 2008 Jan; 15(1):99-109. PubMed ID: 17705027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of metastatic brain tumor growth by intramuscular administration of the endostatin gene.
    Oga M; Takenaga K; Sato Y; Nakajima H; Koshikawa N; Osato K; Sakiyama S
    Int J Oncol; 2003 Jul; 23(1):73-9. PubMed ID: 12792778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis.
    Shibata MA; Morimoto J; Doi H; Morishima S; Naka M; Otsuki Y
    Cancer Gene Ther; 2007 Mar; 14(3):268-78. PubMed ID: 17096028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
    Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
    Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Bendrik C; Robertson J; Gauldie J; Dabrosin C
    Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined effects of endostatin gene transfer and ionizing radiation on lung adenocarcinoma model of A549-cells].
    Ling CH; Ji C; Chen YB; Fu JX; Zhou JY; Chen WC; Yang JC; Su LY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):683-6. PubMed ID: 16200871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas.
    Shibata MA; Ito Y; Morimoto J; Kusakabe K; Yoshinaka R; Otsuki Y
    J Gene Med; 2006 Mar; 8(3):335-52. PubMed ID: 16345101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of M-CSF and/or IFN-gamma gene cotransfected-macrophages by intratumoral injection].
    Lei H; Cao X; Yu Y
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):174-7. PubMed ID: 10920999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
    Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
    Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abdulsamad K; Adams SL
    Immunol Invest; 2008; 37(4):315-38. PubMed ID: 18569073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.